Allergic symptoms accompanied by myocardial ischemic symptoms are defined as Kounis syndrome. Etofenamate is a safe and effective non-steroidal antiinflammatory drug that has widespread utilization. We hereby present a 71-year-old man with Kounis syndrome. Following intramuscular 1 g etofenamate injection, the clinical presentation when admitted to the emergency department (ED) was erythematous rash, pruritus, nausea and vomiting, dizziness, diaphoresis, and chest pain resulting in cardiopulmonary arrest. After 10 minutes of successful cardiopulmonary resuscitation, the electrocardiogram revealed acute inferior myocardial infarction. Patients who admit to the ED with allergic symptoms accompanied by chest pain should consider Kounis syndrome for prompt management. Electrocardiographic examination should be an essential part of the initial evaluation in such patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5543/tkda.2012.03592 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Kounis Syndrome Following a Wasp Sting.
Am J Forensic Med Pathol
January 2025
From the Department of Forensic Medicine, University of Pretoria, Prinshof Campus, Pretoria, South Africa.
Resuscitation of a case of allergy, infarction, and ventricular fibrillation: Kounis syndrome type II and literature review.
Am J Transl Res
December 2024
Department of Emergency Medicine, Yangpu Hospital, School of Medicine, Tongji University Shanghai, China.
To study a case of Kounis syndrome (KS) type II, characterized by allergy, myocardial infarction, and ventricular fibrillation. A patient diagnosed with KS type II was admitted to Yangpu Hospital, School of Medicine, Tongji University in 2021. After systemic treatment, routine investigations, including blood tests, electrocardiography (ECG), and biochemical and coagulation analyses, were performed.
View Article and Find Full Text PDFKounis syndrome manifesting with myocardial infarction due to bi-coronary late stent thrombosis following anaphylaxis.
J Invasive Cardiol
January 2025
Klinikum Fürth, Department of Cardiology and Pneumology, Academic Teaching Hospital of the Friedrich-Alexander-University Erlangen-Nuremberg, Fürth, Germany.
Kounis Syndrome Following Moxifloxacin and Deflazacort Administration.
Eur J Case Rep Intern Med
December 2024
Emergency Department, Ente Ospedaliero Cantonale - Ospedale Regionale di Lugano, Lugano, Switzerland.
Unlabelled: Kounis syndrome (KS), characterized by the simultaneous occurrence of acute coronary syndrome (ACS) and allergic reactions, can be triggered by a range of factors and drugs. We report on the case of a patient who arrived at our emergency department (ED) with symptoms of an allergic reaction after taking moxifloxacin and deflazacort orally. In the ED, the patient experienced a 5-minute episode of oppressive chest pain.
View Article and Find Full Text PDFKounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management.
Hum Vaccin Immunother
December 2024
Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Article Synopsis
- Kounis syndrome is an acute coronary condition triggered by allergic reactions, resulting in heart damage and, in some cases, anaphylactic shock.
- This syndrome can occur as a rare side effect of COVID-19 vaccinations, highlighting the need for further case studies to improve understanding and treatments.
- Analysis of data from 15 patients revealed that the first vaccine dose is more likely to cause Kounis syndrome, emphasizing the importance of prompt diagnosis and monitoring for cardiac symptoms after vaccination.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!